Carrie Melvin - Jun 21, 2022 Form 3 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
COO
Signature
/s/ Lara Meisner, Attorney-in-Fact for Carrie Melvin
Stock symbol
VRDN
Transactions as of
Jun 21, 2022
Transactions value $
$0
Form type
3
Date filed
6/24/2022, 05:23 PM
Next filing
Feb 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VRDN Stock Option (Right to Buy) Jun 21, 2022 Common Stock 210K $10.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on June 21, 2023 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date.

Remarks:

Exhibit 24 - Power of Attorney